BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25986849)

  • 1. "Target-Site" Drug Metabolism and Transport.
    Foti RS; Tyndale RF; Garcia KL; Sweet DH; Nagar S; Sharan S; Rock DA
    Drug Metab Dispos; 2015 Aug; 43(8):1156-68. PubMed ID: 25986849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renal failure on drug transport and metabolism.
    Sun H; Frassetto L; Benet LZ
    Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous expression of human drug-metabolizing enzymes.
    Guengerich FP; Parikh A; Johnson EF; Richardson TH; von Wachenfeldt C; Cosme J; Jung F; Strassburg CP; Manns MP; Tukey RH; Pritchard M; Fournel-Gigleux S; Burchell B
    Drug Metab Dispos; 1997 Nov; 25(11):1234-41. PubMed ID: 9351898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.
    Zhang L; Zhang Y; Huang SM
    Mol Pharm; 2009; 6(6):1766-74. PubMed ID: 19839641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport vs. Metabolism: What Determines the Pharmacokinetics and Pharmacodynamics of Drugs? Insights From the Extended Clearance Model.
    Patilea-Vrana G; Unadkat JD
    Clin Pharmacol Ther; 2016 Nov; 100(5):413-418. PubMed ID: 27448198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporter-mediated drug delivery: recent progress and experimental approaches.
    Sai Y; Tsuji A
    Drug Discov Today; 2004 Aug; 9(16):712-20. PubMed ID: 15341785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.
    Morgan ET; Dempsey JL; Mimche SM; Lamb TJ; Kulkarni S; Cui JY; Jeong H; Slitt AL
    Drug Metab Dispos; 2018 May; 46(5):503-513. PubMed ID: 29514828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety.
    Lu AY
    Drug Metab Dispos; 1998 Dec; 26(12):1217-22. PubMed ID: 9860931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Assessment In Vitro of Transporter and Metabolic Processes in Hepatic Drug Clearance: Use of a Media Loss Approach.
    Harrison J; De Bruyn T; Darwich AS; Houston JB
    Drug Metab Dispos; 2018 Apr; 46(4):405-414. PubMed ID: 29439129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Frontiers in Drug Delivery.
    Tibbitt MW; Dahlman JE; Langer R
    J Am Chem Soc; 2016 Jan; 138(3):704-17. PubMed ID: 26741786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the transport properties of metabolites: case studies and considerations for drug development.
    Zamek-Gliszczynski MJ; Chu X; Polli JW; Paine MF; Galetin A
    Drug Metab Dispos; 2014 Apr; 42(4):650-64. PubMed ID: 24346835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Metabolism in the Liver.
    Almazroo OA; Miah MK; Venkataramanan R
    Clin Liver Dis; 2017 Feb; 21(1):1-20. PubMed ID: 27842765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
    Kearns GL
    Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug disposition and drug-drug interaction data in 2013 FDA new drug applications: a systematic review.
    Yu J; Ritchie TK; Mulgaonkar A; Ragueneau-Majlessi I
    Drug Metab Dispos; 2014 Dec; 42(12):1991-2001. PubMed ID: 25271211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury: the role of drug metabolism and transport.
    Corsini A; Bortolini M
    J Clin Pharmacol; 2013 May; 53(5):463-74. PubMed ID: 23436293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.